NO20053681L - Dispersjon av smaksmaskerte krystaller eller granuler av aktive forbindelser, tyggbare blote kapsler fylt med nevnte dispersjon og fremgangsmate for fremstilling derav - Google Patents
Dispersjon av smaksmaskerte krystaller eller granuler av aktive forbindelser, tyggbare blote kapsler fylt med nevnte dispersjon og fremgangsmate for fremstilling deravInfo
- Publication number
- NO20053681L NO20053681L NO20053681A NO20053681A NO20053681L NO 20053681 L NO20053681 L NO 20053681L NO 20053681 A NO20053681 A NO 20053681A NO 20053681 A NO20053681 A NO 20053681A NO 20053681 L NO20053681 L NO 20053681L
- Authority
- NO
- Norway
- Prior art keywords
- dispersion
- granules
- crystals
- preparation
- chewable
- Prior art date
Links
- 239000006185 dispersion Substances 0.000 title abstract 4
- 239000013078 crystal Substances 0.000 title abstract 3
- 239000008187 granular material Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
Foreliggende oppfinnelse omhandler en dispersjon av krystaller eller granuler av aktiv substans i et lipofilt vehikkel, krystallene eller granulene er belagt med et belegg for smaksmaskerende formål. Oppfinnelsen omhandler også enhetsdoseringsformer og fortrinnsvis tyggbare eller hurtigoppløsende myke gelatinkapsler fylt med dispersjonen så vel som fremgangsmåte for fremstilling derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0300824A FR2850275B1 (fr) | 2003-01-24 | 2003-01-24 | Capsules molles a macher contenant une substance active a gout masque |
PCT/US2004/001463 WO2004066925A2 (en) | 2003-01-24 | 2004-01-21 | Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053681L true NO20053681L (no) | 2005-08-23 |
NO339528B1 NO339528B1 (no) | 2016-12-27 |
Family
ID=32669215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053681A NO339528B1 (no) | 2003-01-24 | 2005-07-29 | Dispersjon av krystaller eller granuler av aktiv substans i en lipofil vehikkel, tyggbare myke kapsler og fremgangsmåte for fremstilling derav. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1592402B1 (no) |
JP (1) | JP5371187B2 (no) |
CN (2) | CN103169655A (no) |
AR (1) | AR042902A1 (no) |
AU (1) | AU2004207498B2 (no) |
BR (1) | BRPI0406913B8 (no) |
CA (1) | CA2512988C (no) |
DK (1) | DK1592402T3 (no) |
ES (1) | ES2415660T3 (no) |
FR (1) | FR2850275B1 (no) |
HK (1) | HK1082659A1 (no) |
MX (1) | MXPA05007683A (no) |
NO (1) | NO339528B1 (no) |
NZ (1) | NZ541753A (no) |
PT (1) | PT1592402E (no) |
RU (1) | RU2362546C2 (no) |
SI (1) | SI1592402T1 (no) |
UA (1) | UA84140C2 (no) |
WO (1) | WO2004066925A2 (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005013944A1 (en) * | 2003-08-11 | 2005-02-17 | Merck Frosst Canada Ltd. | Flavored taste-masked pharmaceutical formulation made using a one-step coating process |
US7169385B2 (en) | 2003-09-29 | 2007-01-30 | Ronald G. Udell | Solubilized CoQ-10 and carnitine |
US8124072B2 (en) | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
AU2004277951B2 (en) | 2003-09-29 | 2010-11-11 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
US20070292501A1 (en) * | 2006-06-05 | 2007-12-20 | Udell Ronald G | Chewable soft gelatin capsules |
US20080020022A1 (en) * | 2006-06-05 | 2008-01-24 | Udell Ronald G | Chewable co-enzyme q-10 capsule |
US8343541B2 (en) | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
NZ595270A (en) * | 2007-07-19 | 2013-04-26 | Sucampo Ag | Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
FR2935084B1 (fr) * | 2008-08-19 | 2011-05-06 | Pancosma Sa Pour L Ind Des Produits Biochimiques | Additif pour l'alimentation animale et son procede de preparation |
WO2012140392A1 (en) * | 2011-04-11 | 2012-10-18 | Ayanda Group As | Oral pharmaceutical dispersion compositions |
GB201006218D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
CA2706270C (en) * | 2010-06-03 | 2020-01-07 | Accucaps Industries Limited | Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation |
CA2706272C (en) * | 2010-06-03 | 2020-05-05 | Accucaps Industries Limited | Multi phase soft gel capsules, apparatus and method thereof |
EP2674154B1 (en) * | 2011-02-11 | 2018-08-01 | CTC Bio, Inc. | Sildenafil-free base-containing film preparation and method for producing same |
EP2699267A4 (en) * | 2011-04-18 | 2014-11-12 | Lipidor Ab | LIQUID CARRIER FOR THE ORAL DELIVERY OF A PHARMACOLOGICAL ACTIVE SUBSTANCE |
CN102241782B (zh) * | 2011-05-18 | 2013-01-30 | 清华大学 | 一种淀粉乙酸酯的制备方法及其在去除水中硝酸盐的应用 |
CN102813275B (zh) | 2011-06-10 | 2015-09-30 | 杭州养生堂保健品有限公司 | 一种咀嚼型软胶囊皮和咀嚼型软胶囊 |
DE102012014848A1 (de) * | 2012-07-27 | 2012-10-31 | Heilerde-Gesellschaft Luvos Just GmbH & Co. KG | Heilerde-Zubereitung |
US20150209360A1 (en) * | 2014-01-30 | 2015-07-30 | Orbz, Llc | Oral caffeine delivery composition |
FR3027802B1 (fr) * | 2014-10-31 | 2018-03-02 | Ethypharm | Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant |
EP3273948B1 (en) | 2015-03-26 | 2020-02-12 | Patheon Softgels Inc. | Liquisoft capsules |
RS63383B1 (sr) | 2016-03-15 | 2022-08-31 | Acer Therapeutics Inc | Sastavi prijatnog ukusa koji uključuju natrijum fenilbutirat i njihova primena |
JP6942342B2 (ja) * | 2016-11-02 | 2021-09-29 | 富士カプセル株式会社 | ソフトカプセル皮膜 |
JP2018121699A (ja) * | 2017-01-30 | 2018-08-09 | 株式会社アクレス | クリルオイルを充填したカプセル剤 |
CN107373744B (zh) * | 2017-07-13 | 2018-11-09 | 云南中烟工业有限责任公司 | 一种维生素c微胶囊的制备方法及其在卷烟中的应用 |
CN108524464A (zh) * | 2018-05-17 | 2018-09-14 | 安士制药(中山)有限公司 | 一种西甲硅油软胶囊的制备方法 |
EP3927312B1 (en) * | 2019-02-22 | 2023-09-13 | Catalent U.K. Swindon Zydis Limited | Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen |
AR118159A1 (es) | 2019-02-22 | 2021-09-22 | Catalent Uk Swindon Zydis Ltd | Minimización de aglomeración, aireación y conservación del revestimiento de composiciones farmacéuticas que comprenden ibuprofeno |
SG11202109022UA (en) * | 2019-02-22 | 2021-09-29 | Catalent Uk Swindon Zydis Ltd | Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products |
JP2023549381A (ja) | 2020-11-18 | 2023-11-24 | バイオファーマ・シナジーズ,エス.エル. | 抗ヒスタミン活性化合物を含む口内分散性粉末組成物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8623557D0 (en) | 1986-10-01 | 1986-11-05 | Boots Co Plc | Therapeutic agents |
US4851226A (en) * | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
CH677606A5 (no) | 1988-07-12 | 1991-06-14 | Aesculapius Pharma Sa | |
US4975465A (en) | 1989-03-28 | 1990-12-04 | American Home Products Corporation | Orally administrable ibuprofen compositions |
CA2063141C (en) * | 1989-08-04 | 1997-03-04 | Edward J. Roche | Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
US5262179A (en) | 1989-09-13 | 1993-11-16 | Nicholas Kiwi Pty Ltd. | Non-effervescent ibuprofen compositions |
RU2101010C1 (ru) | 1990-04-11 | 1998-01-10 | Дзе Апджон Компани | Вкусовая маскировка ибупрофена полимерным покрытием |
JP3157233B2 (ja) * | 1991-11-22 | 2001-04-16 | エーザイ株式会社 | 水溶性薬物を含有した軟カプセル剤 |
JP3136310B2 (ja) * | 1992-02-26 | 2001-02-19 | 東洋カプセル株式会社 | 咀嚼服用に適した担体 |
IT1256022B (it) * | 1992-06-08 | 1995-11-20 | Preparazioni farmaceutiche stabili di nicorandil | |
CA2146999A1 (en) * | 1992-10-16 | 1994-04-28 | Stephen John Douglas | Taste-masking compositions of ranitidine |
GB9313329D0 (en) * | 1993-06-28 | 1993-08-11 | Scherer Ltd R P | Softgel capsule shell compositions |
US5466865A (en) | 1993-07-02 | 1995-11-14 | Ibah, Inc. | Neomorphic ibuprofen and methods of using same |
ZA945944B (en) | 1993-08-13 | 1996-02-08 | Eurand America Inc | Procedure for encapsulating nsaids |
US5569466A (en) * | 1995-05-17 | 1996-10-29 | R. P. Scherer Corporation | Fill compositions for soft elastic gel capsules |
US6024980A (en) * | 1996-06-28 | 2000-02-15 | Mcneil-Ppc, Inc. | Multiphase soft gelatin dosage form |
FR2785539B1 (fr) * | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Particules enrobees d'ibuprofene cristallin granule |
DE60040214D1 (de) * | 1999-02-26 | 2008-10-23 | Shionogi & Co | Kaubare weichkapseln mit verbesserten verabreichungseigenschaften sowie verfahren zu deren herstellung |
FR2795962B1 (fr) | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
WO2002096392A1 (en) * | 2001-05-31 | 2002-12-05 | Cima Labs Inc. | Taste-masking of highly water-soluble drugs |
-
2003
- 2003-01-24 FR FR0300824A patent/FR2850275B1/fr not_active Expired - Lifetime
-
2004
- 2004-01-21 WO PCT/US2004/001463 patent/WO2004066925A2/en active Application Filing
- 2004-01-21 BR BRPI0406913A patent/BRPI0406913B8/pt active IP Right Grant
- 2004-01-21 SI SI200432050T patent/SI1592402T1/sl unknown
- 2004-01-21 NZ NZ541753A patent/NZ541753A/en not_active IP Right Cessation
- 2004-01-21 UA UAA200508284A patent/UA84140C2/ru unknown
- 2004-01-21 CN CN2013100519606A patent/CN103169655A/zh active Pending
- 2004-01-21 CA CA2512988A patent/CA2512988C/en not_active Expired - Lifetime
- 2004-01-21 ES ES04704035T patent/ES2415660T3/es not_active Expired - Lifetime
- 2004-01-21 CN CNA2004800026701A patent/CN1741787A/zh active Pending
- 2004-01-21 PT PT47040357T patent/PT1592402E/pt unknown
- 2004-01-21 AU AU2004207498A patent/AU2004207498B2/en not_active Expired
- 2004-01-21 RU RU2005126729/15A patent/RU2362546C2/ru active
- 2004-01-21 JP JP2006502898A patent/JP5371187B2/ja not_active Expired - Lifetime
- 2004-01-21 EP EP04704035A patent/EP1592402B1/en not_active Expired - Lifetime
- 2004-01-21 MX MXPA05007683A patent/MXPA05007683A/es active IP Right Grant
- 2004-01-21 DK DK04704035.7T patent/DK1592402T3/da active
- 2004-01-23 AR ARP040100180A patent/AR042902A1/es not_active Application Discontinuation
-
2005
- 2005-07-29 NO NO20053681A patent/NO339528B1/no not_active IP Right Cessation
- 2005-12-22 HK HK05111911.8A patent/HK1082659A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA05007683A (es) | 2005-09-30 |
FR2850275B1 (fr) | 2005-04-08 |
UA84140C2 (ru) | 2008-09-25 |
AU2004207498B2 (en) | 2008-10-30 |
CN1741787A (zh) | 2006-03-01 |
RU2005126729A (ru) | 2006-03-10 |
EP1592402B1 (en) | 2013-03-20 |
BRPI0406913A (pt) | 2006-01-03 |
JP2007525413A (ja) | 2007-09-06 |
WO2004066925A3 (en) | 2004-10-28 |
AR042902A1 (es) | 2005-07-06 |
JP5371187B2 (ja) | 2013-12-18 |
SI1592402T1 (sl) | 2013-08-30 |
AU2004207498A1 (en) | 2004-08-12 |
NO339528B1 (no) | 2016-12-27 |
WO2004066925A2 (en) | 2004-08-12 |
BRPI0406913B1 (pt) | 2016-03-01 |
NZ541753A (en) | 2008-12-24 |
EP1592402A4 (en) | 2009-01-14 |
FR2850275A1 (fr) | 2004-07-30 |
DK1592402T3 (da) | 2013-06-24 |
BRPI0406913B8 (pt) | 2021-05-25 |
CA2512988C (en) | 2015-11-10 |
CN103169655A (zh) | 2013-06-26 |
EP1592402A2 (en) | 2005-11-09 |
CA2512988A1 (en) | 2004-08-12 |
ES2415660T3 (es) | 2013-07-26 |
PT1592402E (pt) | 2013-06-25 |
HK1082659A1 (en) | 2006-06-16 |
RU2362546C2 (ru) | 2009-07-27 |
WO2004066925B1 (en) | 2004-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053681L (no) | Dispersjon av smaksmaskerte krystaller eller granuler av aktive forbindelser, tyggbare blote kapsler fylt med nevnte dispersjon og fremgangsmate for fremstilling derav | |
CY1107975T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου με χημικη συγγενεια προς τον υποδοχεα orl1 | |
NO20062082L (no) | Pellets inneholdende venlafaksinhydroklorid | |
NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
CY1114616T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
NO20053846L (no) | Fremgangsmate for a modifisere legemiddel-krystalldannelse | |
AR042472A1 (es) | Preparaciones de liberacion controlada que comprenden tramadol y topiramato | |
BRPI0511072A (pt) | derivados de alquinila como moduladores dos receptores de glutamato metabotróbico | |
CY1113533T1 (el) | Ετεροαρυλο-υποκατεστημενα παραγωγα κυκλοεξυλο-1,4-διαμινης | |
AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
NO2012017I1 (no) | Benzimidazolderivat, fremgangsmåte for fremstilling derav, medikament inneholdende denne forbindelsen samt anvendelse av forbindelsen. | |
EA200501586A1 (ru) | Фармацевтические продукты | |
JP2010529999A5 (no) | ||
NO20032734L (no) | Nye 1,2-difenylazetidinoner, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og anvendelse av disse forbehandling av sykdommer fra lipidstoffskiftet | |
NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
PE20060500A1 (es) | Derivados de heteroaril sulfamida benzo-fusionada como anticonvulsivantes | |
NO20054006D0 (no) | Cykliske ureaderivater, fremstillingsfremgangsmate derav og farmasoytisk anvendelse av samme som kinaseinhibitorer | |
CL2008002052A1 (es) | Compuestos derivados de pirazol, inhibidores de la 11 beta-hidroxi-esteroide-deshidrogenasa; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y uso para la preparacion de medicamentos para el tratamiento de diabetes, obesidad, trastornos de ingestion de comida o dislipidemia | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
NO20055631L (no) | Doseringsform inneholdende pantoprazol som aktiv ingrediens | |
NO20072290L (no) | Organiske forbindelser. | |
NO20074933L (no) | Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat | |
DK1838315T3 (da) | Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til fremstilling heraf, deres anvendelse som medikament samt medikamenter indeholdende dem | |
NO20045504L (no) | Substituerte tiofener, fremgangsmate for fremstilling, deres anvendelse som medikament eller diagnostisk middel samt et medikament inneholdende disse | |
DK1685096T3 (da) | Pentafluorsulfanyl-benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikamenter indeholdende dem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |